News Thermo Fisher Scientific Inc.

Equities

TMO

US8835561023

Advanced Medical Equipment & Technology

Market Closed - Nyse Other stock markets 04:00:02 2024-12-06 pm EST			5-day change	1st Jan Change
529.36 ^USD	+1.63%		-0.05%	-0.27%

Dec. 04	Thermo Fisher Scientific Insider Sold Shares Worth $10,624,559, According to a Recent SEC Filing	MT
Dec. 04	Thermo Fisher Scientific Launches CTS? Detachable Dynabeads? CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production	CI

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Thermo Fisher Scientific Launches CTS Detachable Dynabeads CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production	Dec. 05	AQ
Thermo Fisher Scientific Insider Sold Shares Worth $10,624,559, According to a Recent SEC Filing	Dec. 04	MT
Thermo Fisher Scientific Launches CTS? Detachable Dynabeads? CD4 and CTS Detachable Dynabeads CD8 to Enhance Cell Therapy Development and Production	Dec. 04	CI
Thermo Fisher Scientific Completes $1B Share Repurchase	Dec. 04	BU
Nephron Research Trims Price Target on Thermo Fisher Scientific to $650 From $675	Dec. 02	MT
CMB International Initiates Thermo Fisher Scientific at Buy With $670 Price Target	Nov. 21	MT
Thermo Fisher Scientific Inc. Presents at 6th Annual Wolfe Research Healthcare Conference 2024, Nov-19-2024 08:00 AM	Nov. 19
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases	Nov. 18	AQ
Thermo Fisher Scientific Authorizes $4 Billion Share Buyback	Nov. 15	MT
Thermo Fisher Board Approves New $4 Billion Stock Buyback	Nov. 15	DJ
Thermo Fisher Scientific Authorizes $4 Billion of Share Repurchases	Nov. 15	BU
Tranche Update on Thermo Fisher Scientific Inc.'s Equity Buyback Plan announced on November 14, 2023.	Nov. 15	CI
Thermo Fisher Scientific Inc. announces an Equity Buyback for $4,000 million worth of its shares.	Nov. 15	CI
Thermo Fisher Scientific Inc.'s Equity Buyback announced on November 14, 2023, has expired with 5,523,139 shares, representing 1.43% for $3,000 million.	Nov. 14	CI
Thermo Fisher Scientific Inc. authorizes a Buyback Plan.	Nov. 14	CI
OncoHost Announces Executive Appointment of Ron Andrews	Nov. 14	AQ
Mainz Biomed, Thermo Fisher Partner to Develop Colorectal Cancer Screening Test	Nov. 12	MT
Mainz Biomed and Thermo Fisher Scientific Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets	Nov. 12	AQ
Mainz Biomed N.V. and Thermo Fisher Scientific Inc. Sign a Collaboration Agreement for the Development of Next Generation Colorectal Cancer Screening Product for Global Markets	Nov. 12	CI
Thermo Fisher Scientific to Present at the Wolfe 2024 Healthcare Conference on November 19, 2024	Nov. 11	BU
Quidelortho Corporation Announces Executive Changes	Nov. 08	CI
Thermo Fisher Scientific Keeps Quarterly Dividend at $0.39/Share, Payable Jan. 15 to Holders on Dec. 13	Nov. 07	MT
Thermo Fisher Scientific Declares Quarterly Dividend	Nov. 07	BU
Thermo Fisher Scientific Inc. Declares Quarterly Cash Dividend, Payable on January 15, 2025	Nov. 07	CI
Seer Enters into A Co-Marketing and Sales Agreement with Thermo Fisher Scientific	Nov. 06	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Thermo Fisher opens the biotech ball with a bang

July 25, 2024 at 10:56 am EDT